Rules › DEA-2026-1585

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

Proposed rule from the Justice Department, Drug Enforcement Administration (docket DEA-2026-1585). 4 comment letters from companies and organizations are listed below.

Agency
Justice Department, Drug Enforcement Administration
Docket
DEA-2026-1585
Published
2026-09-23
Comments due
2026-10-23
Status
Comment period closed October 23, 2026 · no final rule found yet
Total public comments
267
Letters listed here
4

Federal Register notice ↗ · Docket on Regulations.gov ↗

Who commented, by industry

Healthcare 3 Other 1

Who commented

Pinney Associates, Inc. Company Other

filed 2026-10-23

The STARR Coalition Trade or professional group Healthcare

filed 2026-10-09

Whole Health Warriors Hospital or health provider Healthcare

filed 2026-10-01

Journal of Psychedelic Psychiatry Company Healthcare

filed 2026-09-28